EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Detecting Alzheimer's disease using digital virtual reality cognitive tests

Lili Fang, Xiang Fan, Anqi Li, Yue Cai, Pan Sun, Zhuonan Wei, Hui Chen, Keyan Yu, Guoyu Lan, Fernando Gonzalez-Ortiz, Lin Liu, Yiying Wang und 12 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.71039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Lili Fang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Virtual Reality, Neuropsychological Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Guangdong Basic and Applied Basic Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Digital biomarkers for detecting Alzheimer's disease (AD) remain controversial due to inconsistent accuracy and unclear relationships with AD core biomarkers. METHODS This study recruited 428 Chinese older adults to determine the associations of artificial intelligence (AI)‐assisted virtual reality (VR) cognitive scores with plasma amyloid beta (Aβ) 42 /Aβ 40 , phosphorylated tau (p‐tau) 217 , glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), Aβ positron emission tomography (PET), tau PET, neurodegeneration, and cognition using generalized linear models, including age, sex, education, and apolipoprotein E ε4 as covariates. RESULTS The AI‐VR cognitive scores were significantly correlated with plasma Aβ 42 /Aβ 40 , p‐tau 217 , GFAP, NfL, Aβ PET, tau PET, hippocampal atrophy, temporal meta‐region of interest cortical thinning, and cortical mean diffusivity increases, accurately identifying cognitively impaired patients from unimpaired individuals (area under curve [AUC]: 0.908–0.969) as well as classifying Aβ PET–positive individuals from negative group (AUC: 0.771–0.991). DISCUSSION This study comprehensively examined the capacity of a 5‐minute AI‐VR cognitive test for identifying abnormal cognition and AD biomarkers, offering a reliable digital marker for early AD detection in community settings. Highlights Digital virtual‐reality cognitive tests correlate with AD biomarkers Digital virtual‐reality cognitive tests can identify cognitive impairment Digital virtual‐reality cognitive tests can classify those who are amyloid beta positron emission tomography positive from negative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseVirtual RealityNeuropsychological TestsHumansMaleFemaleAgedPositron-Emission TomographyAmyloid beta-PeptidesBiomarkerstau ProteinsArtificial IntelligenceCognitive DysfunctionMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerdiagnosisdigital cognitive test

Substanzen

Amyloid beta-PeptidesBiomarkerstau Proteins

Autor:innen und Institutionen

  • Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, China.
  • Department of Medical Imaging, Peking University Shenzhen Hospital, Shenzhen, China.
  • Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, China.
  • Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.
  • School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • School of Biomedical Engineering, Hainan University, Haikou, China.

ORCID-Profile: Tengfei Guo

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Program
  • Guangdong Basic and Applied Basic Science Foundation
  • Shenzhen Bay Laboratory
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Fang, L., Fan, X., Li, A., Cai, Y., Sun, P., Wei, Z., Chen, H., Yu, K., Lan, G., Gonzalez-Ortiz, F., Liu, L., Wang, Y., He, Z., Zhou, X., Zhang, L., Jiang, M., Chen, L., Lu, G., Hu, L., …, & Guo, T. (2025). Detecting Alzheimer's disease using digital virtual reality cognitive tests. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71039

Vancouver

Fang L, Fan X, Li A, Cai Y, Sun P, Wei Z, et al. Detecting Alzheimer's disease using digital virtual reality cognitive tests. Alzheimer's & Dementia. 2025. doi:10.1002/alz.71039

BibTeX
@article{Fang2025,
  author = {Fang, Lili and Fan, Xiang and Li, Anqi and Cai, Yue and Sun, Pan and Wei, Zhuonan and Chen, Hui and Yu, Keyan and Lan, Guoyu and Gonzalez-Ortiz, Fernando and Liu, Lin and Wang, Yiying and He, Zhengbo and Zhou, Xin and Zhang, Laihong and Jiang, Mingxing and Chen, Lele and Lu, Gaigai and Hu, Lin and Liu, Zhen and Blennow, Kaj and Shi, Dai and Cheng, Guanxun and Guo, Tengfei},
  title = {Detecting Alzheimer's disease using digital virtual reality cognitive tests},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.71039}
}
Kostenlos starten →